Literature DB >> 321478

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.

K Bridges, E J Lowbury.   

Abstract

Topical chemoprophylaxis of extensive burns with silver sulphadiazine cream led to a large increase in the proportion of sulphadiazine-resistant Gram-negative bacilli in a burns unit. When all sulphonamide treatment in the ward was stopped; the incidence of sulphonamide-resistant strains fell back to levels similar to those recorded when silver sulphadiazine treatment was introduced. This was associated with a large reduction in the incidence of resistance of certain Gram-negative bacilli (especially Klebstella sp) to several antibiotics. Transferable resistance to sulphadiazine, shown by conjugation experiments with Escherichia coli K12, was found in a majority of the strains of Klebsiella sp tested, and in other species. A pattern of transferable resistance to tetracycline, cephaloridine, chloramphenicol, ampicillin, carbenicillin, and sulphadiazine (T Ce Cl A Ca S) was found in four of the 22 strains of Klebsiella tested, and closely related patterns were transferred by five other strains. These patterns of resistance were commonly found in Klebsiella sp isolated from burns in the period before the withdrawal of sulphonamides from the ward but were found in none of the Klebsiella strains isolated in the first six months after that period. Strains of Acinetobacter and Proteus, in which transferable resistance was not found, showed no appreciable fall or rise in sulphadiazine resistance; there was no fall in resistance of these organisms to tetracycline, cephaloridine, chloramphenicol, ampicillin or carbenicillin on withdrawal of sulphonamides from the ward, but there were substantial falls in resistance of Acinetobacter to kanamycin, gentamicin, trimethoprim, and tetracycline which were probably not caused by the withdrawal of sulphonamides.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321478      PMCID: PMC476342          DOI: 10.1136/jcp.30.2.160

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Prophylactic chemotherapy for burns. Studies on the local and systemic use of combined therapy.

Authors:  J S CASON; E J LOWBURY
Journal:  Lancet       Date:  1960-09-03       Impact factor: 79.321

2.  Bacteriological control of aureomycin therapy.

Authors:  E TOPLEY; E J L LOWBURY; L HURST
Journal:  Lancet       Date:  1951-01-13       Impact factor: 79.321

3.  Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa.

Authors:  E J Lowbury; J R Babb; E Roe
Journal:  Lancet       Date:  1972-11-04       Impact factor: 79.321

4.  Alternative forms of local treatment for burns.

Authors:  E J Lowbury; H A Lilly; J S Cason; D M Jackson; J P Bull; J W Davies; P M Ford
Journal:  Lancet       Date:  1971-11-20       Impact factor: 79.321

5.  Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators.

Authors:  J S Cason; D M Jackson; E J Lowbury; C R Ricketts
Journal:  Br Med J       Date:  1966-11-26

6.  Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.

Authors:  E J Lowbury; D M Jackson; C R Ricketts; B Davis
Journal:  Injury       Date:  1971-07       Impact factor: 2.586

7.  Topical and systemic antibacterial agents in the treatment of burns.

Authors:  R P Hummel; B G MacMillan; W A Altemeier
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

8.  Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics.

Authors:  D J Price; J D Sleigh
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

9.  Changes in antibiotic sensitivity patterns of Gram-negative bacilli in burns.

Authors:  E Roe; E J Lowbury
Journal:  J Clin Pathol       Date:  1972-02       Impact factor: 3.411

10.  Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli.

Authors:  E J Lowbury; J R Babb; K Bridges; D M Jackson
Journal:  Br Med J       Date:  1976-02-28
View more
  4 in total

1.  Gentamicin- and silver-resistant pseudomonas in a burns unit.

Authors:  K Bridges; A Kidson; E J Lowbury; M D Wilkins
Journal:  Br Med J       Date:  1979-02-17

Review 2.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

3.  Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems.

Authors:  Jean-Yves Maillard
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

4.  Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.